BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Marcelin JR, Beam E, Razonable RR. Cytomegalovirus infection in liver transplant recipients: Updates on clinical management. World J Gastroenterol 2014; 20(31): 10658-10667 [PMID: 25152570 DOI: 10.3748/wjg.v20.i31.10658]
URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10658.htm
Number Citing Articles
1
Emanuele Nicastro, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation2019; : 593 doi: 10.1007/978-3-319-96400-3_34
2
Jassin Rashidi‐Alavijeh, Jens Christoph Crämer, Helena Louisa Sauter, Katharina Willuweit, Katja Straub, Heiner Wedemeyer, Kerstin Herzer. Primary sclerosing cholangitis as an independent risk factor for cytomegalovirus infection after liver transplantTransplant Infectious Disease 2021; 23(3) doi: 10.1111/tid.13553
3
Nurettin Dogan, Anna Hüsing-Kabar, Hartmut H. Schmidt, Vito R. Cicinnati, Susanne Beckebaum, Iyad Kabar. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failureJournal of International Medical Research 2018; 46(9): 3979 doi: 10.1177/0300060518785543
4
Hannah Nam, Kathy M. Nilles, Josh Levitsky, Michael G. Ison. Donor-derived Viral Infections in Liver TransplantationTransplantation 2018; 102(11): 1824 doi: 10.1097/TP.0000000000002326
5
Kristen G. Valencia Deray, Kathleen E. Hosek, Divya Chilukuri, Jordan R. Dunson, David R. Spielberg, Sarah J. Swartz, Joseph A. Spinner, Daniel H. Leung, Elizabeth A. Moulton, Flor M. Munoz, Gail J. Demmler-Harrison, Claire E. Bocchini. Epidemiology and long-term outcomes of cytomegalovirus DNAemia and disease in pediatric solid organ transplant recipientsAmerican Journal of Transplantation 2022; 22(1): 187 doi: 10.1111/ajt.16822
6
Norrapat Onpoaree, Anapat Sanpavat, Palittiya Sintusek. Cytomegalovirus infection in liver-transplanted childrenWorld Journal of Hepatology 2022; 14(2): 338-353 doi: 10.4254/wjh.v14.i2.338
7
Hanna L. Kleiboeker, Margaret R. Jorgenson, Glen E. Leverson, John P. Rice, Christopher M. Saddler, Jeannina A. Smith, David Al‐Adra. Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomesTransplant Infectious Disease 2022; 24(4) doi: 10.1111/tid.13898
8
Venancio Avancini Ferreira Alves. Practical Hepatic Pathology: a Diagnostic Approach2018; : 191 doi: 10.1016/B978-0-323-42873-6.00013-5
9
Andrew D. Clouston, Stefan G. Hübscher. MacSween's Pathology of the Liver2024; : 947 doi: 10.1016/B978-0-7020-8228-3.00014-4
10
P. Czarnecka, K. Czarnecka, O. Tronina, M. Durlik. Cytomegalovirus Disease After Liver Transplant—A Description of a Treatment-Resistant Case: A Case Report and Literature ReviewTransplantation Proceedings 2018; 50(10): 4015 doi: 10.1016/j.transproceed.2018.05.014
11
Diagnostic Pathology: Hepatobiliary and Pancreas2017; : 72 doi: 10.1016/B978-0-323-44307-4.50029-4
12
Venancio Avancini Ferreira Alves. Acute Viral Hepatitis: Beyond A, B, and CSurgical Pathology Clinics 2018; 11(2): 251 doi: 10.1016/j.path.2018.02.014
13
Non-Neoplastic Diseases of the Liver2022; : 353 doi: 10.55418/9781933477183-11
14
Karen C. Tsai, Lara A. Danziger-Isakov, David B. Banach. Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on PreventionCurrent Infectious Disease Reports 2016; 18(2) doi: 10.1007/s11908-015-0511-8
15
Margaret R. Jorgenson, Jillian L. Descourouez, Glen E. Leverson, Erin K. McCreary, Michael R. Lucey, Jeannina A. Smith, Robert R. Redfield. High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant RecipientsAnnals of Pharmacotherapy 2018; 52(1): 5 doi: 10.1177/1060028017728296
16
Andrew D. Clouston, Stefan G. Hübscher. Macsween's Pathology of the Liver2018; : 880 doi: 10.1016/B978-0-7020-6697-9.00014-5
17
Cornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, Silke Templin, Steffen Zopf, Gerald Denk, Dennis Eurich, Johann Pratschke, Johannes Weiss, Felix Braun, Martin-Walter Welker, Tim Zimmermann, Petra Knipper, Dirk Nierhoff, Thomas Lorf, Elmar Jäckel, Hans-Michael Hau, Tung Yu Tsui, Aristoteles Perrakis, Hans-Jürgen Schlitt, Kerstin Herzer, Frank Tacke. Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant CentersJournal of Clinical Medicine 2020; 9(8): 2352 doi: 10.3390/jcm9082352
18
Ekta Gupta, Viniyendra Pamecha, Yogita Verma, Niteen Kumar, Archana Rastogi, Nadeem Hasnian, Ajeet Singh Bhadoria. Pre-Transplant Cytomegalovirus Immunoglobulin G Antibody Levels Could Prevent Severe Cytomegalovirus Infections Post-Transplant in Liver Transplant Recipients: Experience from a Tertiary Care Liver CentreIndian Journal of Medical Microbiology 2017; 35(4): 499 doi: 10.4103/ijmm.IJMM_17_201
19
Yoshitomo Morinaga, Yasushi Sawayama, Masaaki Hidaka, Sayaka Mori, Jun Taguchi, Mitsuhisa Takatsuki, Susumu Eguchi, Yasushi Miyazaki, Katsunori Yanagihara. Diagnostic Utility of Cytomegalovirus Nucleic Acid Testing during Antigenemia-Guided Cytomegalovirus Monitoring after Hematopoietic Stem Cell Transplantation or Liver TransplantationThe Tohoku Journal of Experimental Medicine 2019; 247(3): 179 doi: 10.1620/tjem.247.179
20
Annikka Weissferdt. Diagnostic Thoracic Pathology2020; : 3 doi: 10.1007/978-3-030-36438-0_1
21
Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Young Eun Ha, Dong Hyun Sinn, Gyu-Seong Choi, Kyong Ran Peck, Suk-Koo Lee, Kwan Man. Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant RecipientsPLOS ONE 2015; 10(5): e0123554 doi: 10.1371/journal.pone.0123554
22
Manasvi Gupta, Gaurav Manek, Kaitlyn Dombrowski, Rakhi Maiwall. Newer developments in viral hepatitis: Looking beyond hepatotropic virusesWorld Journal of Meta-Analysis 2021; 9(6): 522-542 doi: 10.13105/wjma.v9.i6.522
23
Lydia Sastre, Raquel García, Julián-Gonzalo Gándara, Pablo Ruiz, Julissa Lombardo, Jordi Colmenero, Miquel Navasa, Gonzalo Crespo. Incidence, Predictors, and Impact on Survival of Long-term Cardiovascular Events After Liver TransplantationTransplantation 2020; 104(2): 317 doi: 10.1097/TP.0000000000002852
24
B. Sharmila Mohanraj, Amol S. Rangnekar, Joseph G. Timpone. Principles and Practice of Transplant Infectious Diseases2019; : 41 doi: 10.1007/978-1-4939-9034-4_3
25
D. Topalis, S. Gillemot, R. Snoeck, G. Andrei. Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseNucleic Acids Research 2016; : gkw875 doi: 10.1093/nar/gkw875
26
Annalisa Boscolo, Eugenia Menin, Beatrice Zelaschi, Laura Albertoni, Giacomo Zanus, Fabio Baratto. Early Use of Etanercept for Graft-Versus-Host Disease After Liver Transplant: the Importance of Broad Spectrum Infective ProphylaxisExperimental and Clinical Transplantation 2020; 18(1): 123 doi: 10.6002/ect.2017.0231
27
S. Ciesek, H. Wedemeyer. Virale Infektionen bei LebertransplantiertenDer Gastroenterologe 2020; 15(3): 227 doi: 10.1007/s11377-020-00434-x
28
Andy Roemhild, Petra Reinke. Virus-specific T-cell therapy in solid organ transplantationTransplant International 2016; 29(5): 515 doi: 10.1111/tri.12659
29
Yoshinori Harada, Masaki Iwai. Diagnosis of Liver Disease2019; : 35 doi: 10.1007/978-981-13-6806-6_3
30
Chalermrat Bunchorntavakul, K. Rajender Reddy. Epstein-Barr Virus and Cytomegalovirus Infections of the LiverGastroenterology Clinics of North America 2020; 49(2): 331 doi: 10.1016/j.gtc.2020.01.008
31
Anne M. Larson, George B. McDonald. Transplant Infections2016; : 653 doi: 10.1007/978-3-319-28797-3_36
32
James M. Neuberger, Wolf O. Bechstein, Dirk R.J. Kuypers, Patrizia Burra, Franco Citterio, Sabina De Geest, Christophe Duvoux, Alan G. Jardine, Nassim Kamar, Bernhard K. Krämer, Herold J. Metselaar, Frederik Nevens, Jacques Pirenne, Manuel L. Rodríguez-Perálvarez, Didier Samuel, Stefan Schneeberger, Daniel Serón, Pavel Trunečka, Giuseppe Tisone, Teun van Gelder. Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant RecipientsTransplantation 2017; 101(4S): S1 doi: 10.1097/TP.0000000000001651
33
Monika Lindemann, Benjamin Wilde, Justa Friebus-Kardash, Anja Gäckler, Oliver Witzke, Ulf Dittmer, Peter A. Horn, Andreas Kribben, Nils Mülling, Ute Eisenberger. Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney TransplantationDiagnostics 2021; 11(9): 1688 doi: 10.3390/diagnostics11091688
34
Sandra Ciesek, Heiner Wedemeyer. Virale Infektionen bei LebertransplantiertenWiener klinisches Magazin 2020; 23(5): 240 doi: 10.1007/s00740-020-00352-2
35
Xiao Wang, Yanqun Xu, Dorothy E. Scott, Haruhiko Murata, Evi B. Struble. Binding and neutralizing anti-cytomegalovirus activities in immune globulin productsBiologicals 2017; 50: 35 doi: 10.1016/j.biologicals.2017.09.004
36
Shunji Nagai, Richard S. Mangus, Eve Anderson, Burcin Ekser, Chandrashekhar A. Kubal, Jonathan A. Fridell, A. Joseph Tector. Cytomegalovirus Infection After Intestinal/Multivisceral TransplantationTransplantation 2016; 100(2): 451 doi: 10.1097/TP.0000000000000832
37
Smaranda Gliga, Melanie Fiedler, Theresa Dornieden, Anne Achterfeld, Andreas Paul, Peter A. Horn, Kerstin Herzer, Monika Lindemann. Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant RecipientsVaccines 2021; 9(2): 88 doi: 10.3390/vaccines9020088
38
Munehiro Furuichi, Takeo Fujiwara, Akinari Fukuda, Mureo Kasahara, Isao Miyairi. Fulminant Hepatic Failure as a Risk Factor for Cytomegalovirus Infection in Children Receiving Preemptive Therapy After Living Donor Liver TransplantationTransplantation 2016; 100(11): 2404 doi: 10.1097/TP.0000000000001435
39
Irmeli Lautenschlager, Raisa Loginov, Heikki Mäkisalo, Krister Höckerstedt. Prospective long-term study on primary CMV infections in adult liver transplant (D+/R−) patients after valganciclovir prophylaxisJournal of Clinical Virology 2015; 71: 73 doi: 10.1016/j.jcv.2015.08.009
40
Nopparak Chanburanavah, Sophida Boonsathorn, Nopporn Apiwattanakul, Chatmanee Lertudomphonwanit, Songpon Getsuwan, Pornthep Tanpowpong, Suporn Treepongkaruna. Risk factors of cytomegalovirus infection after pediatric liver transplantation and effectiveness of preemptive therapyTransplant Infectious Disease 2023; 25(3) doi: 10.1111/tid.14057
41
Rayan El Sibai, Sari R. Freedman, J. David Gatz. A Narrative Review of the Evaluation and Management of Liver Transplant Complications in the Emergency DepartmentThe Journal of Emergency Medicine 2023; 64(5): 596 doi: 10.1016/j.jemermed.2023.02.022
42
Emanuele Nicastro, Sara Giovannozzi, Paola Stroppa, Valeria Casotti, Anna Paola Callegaro, Alessandra Tebaldi, Claudio Farina, Michele Colledan, Lorenzo D'Antiga. Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver TransplantationTransplantation 2017; 101(4): 804 doi: 10.1097/TP.0000000000001531
43
RyungA Kang, Sangbin Han, Jong Man Kim, Kyo Won Lee, Hyo Won Park, Joong Hyun Ahn, Seonwoo Kim, Eun‐Suk Kang, Gaab Soo Kim, Jae‐Won Joh. Postoperative hyperglycemia may negatively impact cytomegalovirus infection in seropositive liver transplant recipients: a retrospective cohort studyTransplant International 2020; 33(1): 68 doi: 10.1111/tri.13496
44
Priya Walabh, David P. Moore, Graham Paget, Anja Meyer, Porai Nthabaleng M. Moshesh, Pravina Walabh, Sechaba T. Palweni, Christina Hajinicolaou. Healthcare disparity and its associations with cytomegalovirus disease in pediatric liver transplant recipients in South AfricaTransplant Infectious Disease 2022; 24(6) doi: 10.1111/tid.13917
45
Marian G. Michaels, Atul Humar. Cytomegalovirus in the Pediatric Transplant RecipientTransplantation 2017; 101(4): 686 doi: 10.1097/TP.0000000000001627
46
Michael Barry. Single-cycle adenovirus vectors in the current vaccine landscapeExpert Review of Vaccines 2018; : 1 doi: 10.1080/14760584.2018.1419067
47
Magdalena Siodlak, Margaret R. Jorgenson, Jillian L. Descourouez, Glen E. Leverson, Didier A. Mandelbrot, Jeannina A. Smith, Robert R. Redfield. Impact of High‐Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant RecipientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2018; 38(7): 694 doi: 10.1002/phar.2126
48
William J. Britt, Mark N. Prichard. New therapies for human cytomegalovirus infectionsAntiviral Research 2018; 159: 153 doi: 10.1016/j.antiviral.2018.09.003